Ipca Laboratories Limited (BOM: 524494)
India
· Delayed Price · Currency is INR
1,546.75
+3.05 (0.20%)
At close: Jan 20, 2025
Ipca Laboratories Revenue
Ipca Laboratories had revenue of 23.55B INR in the quarter ending September 30, 2024, with 15.78% growth. This brings the company's revenue in the last twelve months to 85.34B, up 27.75% year-over-year. In the fiscal year ending March 31, 2024, Ipca Laboratories had annual revenue of 77.06B with 23.33% growth.
Revenue (ttm)
85.34B
Revenue Growth
+27.75%
P/S Ratio
n/a
Revenue / Employee
4.92M
Employees
17,335
Market Cap
392.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 77.06B | 14.58B | 23.33% |
Mar 31, 2023 | 62.48B | 4.18B | 7.16% |
Mar 31, 2022 | 58.31B | 4.10B | 7.56% |
Mar 31, 2021 | 54.21B | 7.71B | 16.58% |
Mar 31, 2020 | 46.50B | 8.75B | 23.18% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,635.60B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |
Ipca Laboratories News
- 19 days ago - Stock Market Update, January 2: Lupin, Eicher Motors, IPCA Laboratories, Mahindra & Mahindra and more hit 52-week highs today - Business Upturn
- 22 days ago - Motilal Oswal maintains ‘buy’ rating on Ipca Labs, expects 21% upside potential - Business Upturn
- 4 weeks ago - IPCA Laboratories shares rise over 2% following promoter’s Rs 600 crore stake sale - Business Upturn
- 5 weeks ago - Pharma stocks: Divi’s Lab (+0.82%), IPCA (+0.83%) rise; Biocon (-1.86%), Glaxo (-1.44%) decline - Business Upturn
- 2 months ago - IPCA Laboratories revises record date to 27th November for Rs. 2 interim dividend - Business Upturn
- 2 months ago - IPCA Laboratories shares surge 2% on strong Q2 results - Business Upturn
- 2 months ago - IPCA Laboratories Q2 FY25 Results: Revenue up 15.8% YoY to Rs 2,354.90 crore, Net Profit up 57.9% YoY to 229.48 crore - Business Upturn
- 2 months ago - Ipca Laboratories Q2 results: Check share price ahead of Q2 results - Business Upturn